Acta Paediatrica · 2005 · 20 citations · 35 references
MedicinePediatricsPharmacotherapyInfant HealthNeonatologyPulmonary Function TestingCare Of Premature InfantsNeonatal PharmacotherapyPediatric PharmacologyPediatric Pulmonary Function TestingRespiratory Distress In NewbornsRespiratory Distress SyndromeDosing In Premature InfantsInfant Pulmonary Function TestingNeonatal Chronic Lung DiseaseNeonatal Respiratory Distress SyndromePediatric Respiratory Distress SyndromePostnatal Corticosteroid TherapyRespiratory Outcomes In PrematurityRespiratory Status Assessment
AIM: To evaluate the pulmonary outcome at corrected age of 2 y on preterm infants who participated in a double-blind trial of early postnatal dexamethasone therapy (< 12 h after birth) for the prevention of chronic lung disease. METHODS: Clinical respiratory status, blood gases, acid-base balance and pulmonary function were evaluated at corrected age of 2 y in 116 preterm infants (59 infants in the control group; 57 in the dexamethasone-treated group). In the dexamethasone-treated group, dexamethasone was administered intravenously every 12 h in tapering doses: 0.25 mg/kg on days 1 through 7, 0.12 mg/kg on days 8 through 14, 0.05 mg/kg on days 15 through 21, and 0.02 mg/kg on days 21 through 28. RESULTS: The clinical and laboratory characteristics in the perinatal period were comparable between the groups. At the time of follow-up (mean +/- SD corrected age was 25.1 +/- 4.8 mo for the control group and 24.6 +/- 5.1 mo for the dexamethasone-treated group), there was a slightly lower mean body weight and body length, and a lower psychomotor developmental index in the dexamethasone-treated group than in the control group (10.9 +/- 2.1 vs 11.5 +/- 1.9 kg, 84.4 +/- 6.1 vs 85.9 +/- 5.8 cm, and 82 +/- 24 vs 89 +/- 26, respectively); however, these differences were not statistically significant. There were no significant differences between the control and dexamethasone-treated groups in clinical respiratory status, blood gases, acid-base balance or in lung mechanics (V(T): 9.5 +/- 2.0 vs 9.4 +/- 1.9 ml/kg; V(min): 0.23 +/- 0.04 vs 0.23 +/- 0.03 l/min/kg; C(RS): 13.1 +/- 3.9 vs 12.6 +/- 3.6 ml/kPa/kg; R(RS): 1.56 +/- 0.64 vs 1.62 +/- 0.58 kPa/l/s, respectively). CONCLUSION: There was no apparent adverse respiratory outcome associated with early postnatal dexamethasone therapy.
35
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Tsu F. Yeh, Yuh J. Lin, Chao Huang et al. · PEDIATRICS · 1998 · 424 citations
CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
Mark C. Mammel, DanaE. Johnson, ThomasP. Green et al. · The Lancet · 1983 · 310 citations
Medicine, Child Health, Pediatrics +10